Numerous proteins have been implicated in neurodegenerative protein aggregation; Aβ1–42 and hP-tau are best known as aggregate markers typical of AD, but they are also constituents of aggregates observed in other neurodegenerative diseases [10,11,12,13]. This evidence concerns the gene MAPT and neurodegenerative disease.